2025 Community Routes: Access to Mental Health Care Grants Awarded to Clinics in Alabama, Mississippi, and Texas, Funded by Teva Pharmaceuticals
Teva Pharmaceuticals has awarded $2 million in new mental health care grants across 11 free and charitable clinics in Alabama, Mississippi, and Texas. This funding is part of a larger $4 million commitment launched in 2022 through the Community Routes initiative. Each clinic will receive $75,000 to expand mental health services in underserved communities.
The program's previous two years have shown significant impact, reaching over 63,000 beneficiaries, conducting 24,617 patient screenings for mental health conditions, and training more than 2,800 community members. The clinics also organized 131 community events to expand mental health education and services.
The 2025 grant recipients include facilities across three states, focusing on initiatives such as integrating behavioral health services into primary care, implementing screening tools, and developing culturally competent services. Key priorities include creating sustainable mental health service models and establishing standardized screening protocols, particularly for depression and anxiety treatment.
Teva Pharmaceuticals ha assegnato 2 milioni di dollari in nuovi finanziamenti per la salute mentale a 11 cliniche gratuite e caritatevoli in Alabama, Mississippi e Texas. Questo finanziamento fa parte di un impegno più ampio di 4 milioni di dollari lanciato nel 2022 attraverso l'iniziativa Community Routes. Ogni clinica riceverà 75.000 dollari per ampliare i servizi di salute mentale nelle comunità svantaggiate.
I risultati dei precedenti due anni del programma hanno mostrato un impatto significativo, raggiungendo oltre 63.000 beneficiari, conducendo 24.617 screening per condizioni di salute mentale e formando più di 2.800 membri della comunità. Le cliniche hanno anche organizzato 131 eventi comunitari per ampliare l'educazione e i servizi sulla salute mentale.
I destinatari dei finanziamenti del 2025 includono strutture in tre stati, concentrandosi su iniziative come l'integrazione dei servizi di salute comportamentale nella cura primaria, l'implementazione di strumenti di screening e lo sviluppo di servizi culturalmente competenti. Le priorità chiave includono la creazione di modelli sostenibili di servizi di salute mentale e l'istituzione di protocolli di screening standardizzati, in particolare per il trattamento della depressione e dell'ansia.
Teva Pharmaceuticals ha otorgado 2 millones de dólares en nuevas subvenciones para el cuidado de la salud mental a 11 clínicas gratuitas y benéficas en Alabama, Mississippi y Texas. Este financiamiento es parte de un compromiso más amplio de 4 millones de dólares lanzado en 2022 a través de la iniciativa Community Routes. Cada clínica recibirá 75.000 dólares para expandir los servicios de salud mental en comunidades desatendidas.
Los resultados de los dos años anteriores del programa han mostrado un impacto significativo, alcanzando a más de 63.000 beneficiarios, realizando 24.617 pruebas de detección para condiciones de salud mental y capacitando a más de 2.800 miembros de la comunidad. Las clínicas también organizaron 131 eventos comunitarios para ampliar la educación y los servicios de salud mental.
Los beneficiarios de las subvenciones de 2025 incluyen instalaciones en tres estados, centrándose en iniciativas como la integración de servicios de salud conductual en la atención primaria, la implementación de herramientas de detección y el desarrollo de servicios culturalmente competentes. Las prioridades clave incluyen la creación de modelos sostenibles de servicios de salud mental y el establecimiento de protocolos de detección estandarizados, particularmente para el tratamiento de la depresión y la ansiedad.
테바 제약은 앨라배마, 미시시피, 텍사스의 11개 무료 및 자선 클리닉에 200만 달러의 정신 건강 관리 보조금을 수여했습니다. 이 자금은 2022년 Community Routes 이니셔티브를 통해 시작된 400만 달러의 더 큰 약속의 일환입니다. 각 클리닉은 소외된 지역 사회에서 정신 건강 서비스를 확장하기 위해 75,000 달러를 받게 됩니다.
프로그램의 이전 2년은 상당한 영향을 보여주었으며, 63,000명 이상의 수혜자에 도달하고, 정신 건강 상태에 대한 24,617건의 환자 선별 검사를 실시하며, 2,800명 이상의 지역 사회 구성원을 교육했습니다. 클리닉은 또한 정신 건강 교육 및 서비스를 확장하기 위해 131개의 지역 사회 이벤트를 조직했습니다.
2025년 보조금 수혜자는 세 개 주에 걸쳐 있는 시설로, 1차 진료에 행동 건강 서비스를 통합하고, 선별 도구를 구현하며, 문화적으로 적합한 서비스를 개발하는 등의 이니셔티브에 중점을 두고 있습니다. 주요 우선 사항에는 지속 가능한 정신 건강 서비스 모델을 만들고, 특히 우울증 및 불안 치료를 위한 표준화된 선별 프로토콜을 설정하는 것이 포함됩니다.
Teva Pharmaceuticals a accordé 2 millions de dollars en nouvelles subventions pour les soins de santé mentale à 11 cliniques gratuites et caritatives dans l'Alabama, le Mississippi et le Texas. Ce financement fait partie d'un engagement plus large de 4 millions de dollars lancé en 2022 dans le cadre de l'initiative Community Routes. Chaque clinique recevra 75 000 dollars pour étendre les services de santé mentale dans les communautés mal desservies.
Les résultats des deux années précédentes du programme ont montré un impact significatif, atteignant plus de 63 000 bénéficiaires, réalisant 24 617 dépistages de patients pour des problèmes de santé mentale et formant plus de 2 800 membres de la communauté. Les cliniques ont également organisé 131 événements communautaires pour élargir l'éducation et les services en santé mentale.
Les bénéficiaires des subventions de 2025 incluent des établissements dans trois États, se concentrant sur des initiatives telles que l'intégration des services de santé comportementale dans les soins primaires, la mise en œuvre d'outils de dépistage et le développement de services culturellement compétents. Les priorités clés incluent la création de modèles de services de santé mentale durables et l'établissement de protocoles de dépistage standardisés, en particulier pour le traitement de la dépression et de l'anxiété.
Teva Pharmaceuticals hat 2 Millionen Dollar in neuen Zuschüssen für die psychische Gesundheitsversorgung an 11 kostenlose und gemeinnützige Kliniken in Alabama, Mississippi und Texas vergeben. Diese Finanzierung ist Teil eines größeren Engagements von 4 Millionen Dollar, das 2022 im Rahmen der Initiative Community Routes ins Leben gerufen wurde. Jede Klinik erhält 75.000 Dollar, um die psychischen Gesundheitsdienste in unterversorgten Gemeinden auszubauen.
Die Ergebnisse der vorherigen zwei Jahre des Programms haben erhebliche Auswirkungen gezeigt, indem über 63.000 Begünstigte erreicht, 24.617 Patienten-Screenings auf psychische Erkrankungen durchgeführt und mehr als 2.800 Mitglieder der Gemeinschaft geschult wurden. Die Kliniken organisierten auch 131 Gemeinschaftsveranstaltungen, um die Aufklärung und die Dienste im Bereich psychische Gesundheit zu erweitern.
Die Empfänger der Zuschüsse für 2025 umfassen Einrichtungen in drei Bundesstaaten, die sich auf Initiativen konzentrieren, wie die Integration von Verhaltensgesundheitsdiensten in die Primärversorgung, die Implementierung von Screening-Tools und die Entwicklung kulturell kompetenter Dienstleistungen. Wichtige Prioritäten sind die Schaffung nachhaltiger Modelle für psychische Gesundheitsdienste und die Etablierung standardisierter Screening-Protokolle, insbesondere für die Behandlung von Depressionen und Angstzuständen.
- None.
- None.
The
SANTA BARBARA, Calif. and PARSIPPANY, N.J. , Feb. 27, 2025 (GLOBE NEWSWIRE) -- Direct Relief, Teva Pharmaceuticals, and the National Association of Free and Charitable Clinics (NAFC) today announced the funding of Community Routes: Access to Mental Health Care grants, awarding
“Every day uninsured patients face barriers to accessing basic mental health services they need,” said Carol Richardson, Sustainability and Health Equity Lead, Teva U.S. “This latest round of grant funding will enable clinics in more states to expand existing or develop innovative new behavioral health programs that meet the needs of their local patient populations”.
Over the first two years, Community Routes grantees demonstrated significant impact across their communities reaching more than 63,000 beneficiaries. Clinics conducted 24,617 patient screenings for depression, anxiety, and adverse childhood experiences, helping identify and address previously unmet mental health needs. The program extended beyond direct patient care, with grantees training more than 2,800 community members, staff, and volunteers in mental health promotion and well-being. Additionally, clinics organized 131 community events to expand access to mental health education and services, strengthening their role as trusted healthcare resources.
Building on these achievements, this funding cycle prioritizes the creation and expansion of innovative care delivery models that integrate behavioral health services into existing clinical operations, with particular emphasis on evidence-based screening tools and treatment protocols for depression and anxiety.
"Mental health is an essential component of overall well-being, yet too many individuals in underserved communities struggle to access the care they need,” shared Nicole Lamoureux, NAFC President & CEO. “This program empowers clinics to bridge this gap by expanding behavioral health services and critical mental health support. By investing in these clinics, we are investing in the health and resilience of entire communities."
The 2025 grant recipients include:
Alabama:
- Medical Outreach Ministries (Montgomery) - Leveraging academic partnerships through the University of Alabama's psychiatry residency program to integrate mental health services into primary care.
- Ozanam Charitable Pharmacy (Mobile) - Implementing screening tools for depression and within pharmacy services and connecting patients to necessary resources.
- St. Michael's Medical Clinic (Anniston) - Integrating mental health services with primary care and social support services to address the complex needs of uninsured and homeless populations.
Mississippi:
- Bethel Free Clinic, Inc. (Biloxi) - Enhancing mental health access for uninsured residents by integrating depression and anxiety screenings into patient care, referring those in need for further evaluation.
Texas:
- Brother Bill's Helping Hand (Dallas) - Improving mental health access for predominantly Latino communities through integrated care, community-based outreach, and culturally competent services.
- Heal the City Free Clinic (Amarillo) - Implementing community-based stigma reduction programs to increase understanding of mental health conditions and encourage individuals to seek support.
- Health for All (Bryan) - Expanding trauma-informed mental health services access for underserved populations and delivering culturally sensitive services tailored to their diverse community’s needs.
- Ibn Sina Foundation (Houston) - Emphasizing equitable access by addressing the distinct mental health needs of multiple underserved populations. Mercy Clinic of Fort Worth - Integrating behavioral health services into routine care and establishing patient navigation systems for uninsured Spanish-speaking patients.
- The Agape Clinic (Dallas) - Developing comprehensive mental health support systems, including therapy, case management, and peer support, for the underserved patient population.
- Woven Health Clinic (Farmers Branch) - Integrating mental health services into primary care by offering screenings for depression and anxiety, connection to individual counseling, and treatment plans.
Selected programs emphasize sustainable integration of mental health services through:
- Implementation of standardized screening protocols
- Supporting the clinical workforce through partnerships
- Integration of behavioral health into primary care
- Extending cultural competency across the full continuum of patient care
- Social service referral networks
"Expanding mental health services in resource-limited settings has been a key focus of prior Community Routes funding, and this latest round will allow providers to reach even more people with critical services," said Katie Lewis, Regional Director of U.S. Programs for Direct Relief. "These funds will allow clinics to build on successful approaches while exploring new strategies that fit the unique needs of the people and communities they serve."
For a report on lessons learned from our Community Routes: Access to Mental Healthcare grantees, click here.
Community Routes: Access to Mental Health Care—a partnership between Teva, Direct Relief and the National Association of Free and Charitable Clinics (NAFC)— is a unique access program that is helping to advance health equity and quality care for underserved populations across the U.S.
Teva is providing commonly used medicines that treat depression and anxiety to 400+ clinics in 10 states, as well as
About Direct Relief
Direct Relief is a humanitarian aid organization, active in all 50 states and more than 80 countries, with a mission to improve the health and lives of people affected by poverty or emergencies. Direct Relief works with healthcare providers operating in resource-limited communities to help them care for their patients by providing essential medical supplies and equipment. Learn more at DirectRelief.org.
About National Association of Free and Charitable Clinics
National Association of Free and Charitable Clinics (NAFC) is the only nonprofit 501c (3) organization whose mission is solely focused on the issues and needs of the medically underserved throughout the nation and the more than 1,400 Free and Charitable Clinics that serve them. The NAFC has earned the Platinum Seal of Transparency from GuideStar and a 4-star rating from Charity Navigator. Founded in 2001 and headquartered near Washington, D.C., the NAFC is working to ensure that the medically underserved have access to affordable quality health care and strives to be a national voice promoting quality health care for all. For more information about the NAFC, please visit www.nafcclinics.org.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, Teva’s commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its 37,000 employees across 57 markets to advance health by developing medicines for the future while championing the production of generics and biologics. If patients have a need, we’re already working to address it. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This document and the presentation at the conference may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to participate and/or fund patient access programs; our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to sustain and focus our portfolio of generics medicines; our substantial indebtedness; our business and operations in general including the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2024, including in the sections captioned "Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
Teva Media Inquiries:
TevaCommunicationsNorthAmerica@tevapharm.com
Teva Investor Relations Inquires
TevaIR@Tevapharm.com
FAQ
How much funding did Teva provide in the 2025 Community Routes mental health grants?
What impact has TEVA's Community Routes program achieved in its first two years?
Which states received TEVA's mental health care grants in 2025?
What is the total commitment of TEVA's Community Routes mental health initiative?
How are the TEVA-funded clinics implementing mental health services?
